使用超短回波时间MRI对囊性纤维化肺部MR信号强度进行体积量化作为自动化评分
这项前瞻性单中心研究纳入30例囊性纤维化患者,验证超短回波时间MRI自动量化高、低信号强度体积与CT及肺功能的相关性。结果显示MR高信号体积与CT高衰减体积相关性良好(ρ=0.70),且MR指标与肺功能及Bhalla评分相关,可重复性几乎完美(ICC>0.95)。自动化量化异常信号强度体积与囊性纤维化严重程度相关,可用于横断面和纵向评估。
要点
- UTE-MRI自动量化的高信号体积与CT高衰减体积相关性良好(ρ=0.70,p<0.001)。
- MR总异常信号体积在有无呼吸急性加重患者间差异显著(p=0.01),M0和M12均如此。
- MR高信号体积变化与FEV1%变化相关(ρ=-0.49,p=0.008),可重复性几乎完美(ICC>0.95)。
关键影像表现/征象
- MRI记录高信号体积百分比(%MR-HSV)、低信号体积百分比(%MR-LSV)和总异常信号体积百分比(%MR-TSV),CT记录相应衰减值(%CT-HAV、%CT-LAV、%CT-TAV)。
- %MR-HSV与%CT-HAV相关性良好(ρ=0.70;p<0.001),%MR-LSV与%CT-LAV相关性良好(ρ=0.60;p<0.001)。
- 自动MR指标与肺功能检查和Bhalla评分相关(p<0.05)。
- %MR-TSV在伴有和不伴有呼吸急性加重的囊性纤维化患者间差异显著(p=0.01),M0和M12均如此。
- %MR-HSV的变化与肺功能检查FEV1%的变化相关(ρ=-0.49;p=0.008)。
诊断标准与关键数值
- 以CT为参考,%MR-HSV与%CT-HAV的Spearman相关系数ρ=0.70(p<0.001),%MR-LSV与%CT-LAV的ρ=0.60(p<0.001)。
- 自动MR指标与肺功能检查和Bhalla评分相关(p<0.05)。
- %MR-TSV在有无呼吸急性加重患者间差异显著(p=0.01)。
- %MR-HSV变化与FEV1%变化的相关系数ρ=-0.49(p=0.008)。
- 可重复性用组内相关系数(ICC)评估,ICC>0.95。
临床应用与阅片要点
- UTE-MRI自动量化高、低信号强度体积可作为评估囊性纤维化结构改变的客观、可重复工具,适用于研究和临床纵向随访。
- 自动量化异常信号强度体积与囊性纤维化严重程度相关,可辅助横断面和纵向评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The study aimed to validate automated quantification of high and low signal intensity volumes using ultrashort echo-time MRI, with CT and pulmonary function test (PFT) as references, to assess the severity of structural alterations in cystic fibrosis (CF).
METHODS: This prospective study was performed in a single center between May 2015 and September 2017. Participants with CF completed clinical examination, CT, MRI, and PFT the same day during routine clinical follow-up (M0), and then 1 year after (M12) except for CT. Using MRI, percentage high (%MR-HSV), low (%MR-LSV), and total abnormal (%MR-TSV) signal intensity volumes were recorded, as well as their corresponding attenuation values using CT (%CT-HAV, %CT-LAV, %CT-TAV, respectively). Automated quantifications and visual Bhalla score were evaluated independently by two observers. Correlations were assessed using the Spearman test, comparisons using the Mann-Whitney test, and reproducibility using the intraclass correlation coefficient (ICC).
RESULTS: A total of 30 participants were enrolled (median age 27 years, 18 men). At M0, there was a good correlation between %MR-HSV and %CT-HAV (ρ = 0.70; p < 0.001) and %MR-LSV and %CT-LAV (ρ = 0.60; p < 0.001). Automated MR metrics correlated to PFTs and Bhalla score (p < 0.05) while %MR-TSV was significantly different between CF with and without respiratory exacerbation (p = 0.01) at both M0 and M12. The variation of %MR-HSV correlated to the variation of FEV1% at PFT (ρ = - 0.49; p = 0.008). Reproducibility was almost perfect (ICCs > 0.95).
CONCLUSIONS: Automated quantification of abnormal signal intensity volumes relates to CF severity and allows reproducible cross-sectional and longitudinal assessment.
TRIAL REGISTRATION: Clinical trial identifier: NCT02449785 KEY POINTS: • Cross-sectionally, the automated quantifications of high and low signal intensity volumes at UTE correlated to the quantification of high and low attenuation using CT as reference. • Longitudinally, the variation of high signal intensity volume at UTE correlated to the variation of pulmonary function test and was significantly reduced in CF with an improvement in exacerbation status. • Automated quantification of abnormal signal intensity volumes are objective and reproducible tools to assess structural alterations in CF and follow-up longitudinally, for both research and clinical purposes.
引用
- Benlala I, Point S, Leung C, et al. Volumetric quantification of lung MR signal intensities using ultrashort TE as an automated score in cystic fibrosis. Eur Radiol. 2020. PMID: 32415586. doi:10.1007/s00330-020-06910-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。